Pediatric differentiated thyroid carcinoma leading to fatal lung fibrosis by Michaela Kuhlen, Marina Kunstreich, Friederike Eilsberger, Markus Luster, Antje Redlich

Get full text

Response to letter: ‘why so many doses, and why now?’ by Michaela Kuhlen, Marina Kunstreich, Friederike Eilsberger, Markus Luster, Antje Redlich

Get full text

Risk-adapted therapy in pediatric thyroid cancer: initial experience from a national reference program by the MET group by Michaela Kuhlen, Marina Kunstreich, Friederike Eilsberger, Kerstin Lorenz, Michael Abele, Ines B Brecht, Dominik T Schneider, Markus Luster, Antje Redlich

Get full text

Mutation-based, neoadjuvant treatment for advanced anaplastic thyroid carcinoma by Sabine Wächter, Detlef K. Bartsch, J. Riera Knorrenschild, Anika Pehl, Friederike Eilsberger, Andreas Pfestroff, Markus Luster, Katharina Holzer, Andreas Neubauer, Elisabeth Maurer

Get full text

Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancer by Jan Taprogge, Iain Murray, Hannah Sharman, Paul Gape, Francesca Leek, Carla Abreu, Lenka Vávrová, Kate Newbold, Kee H Wong, Markus Luster, Frederik A Verburg, Tino Schurrat, Lavinia Vija, Frédéric Courbon, Delphine Vallot, Manuel Bardiès, Sarah Schumann, Uta Eberlein, Michael Lassmann, Glenn Flux

Get full text